Dicerna Pharmaceuticals (DRNA) PT Lowered to $36 at Goldman Sachs

August 6, 2021 8:03 AM EDT Send to a Friend

Goldman Sachs analyst Madhu Kumar ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Dicerna Pharmaceuticals (DRNA) PT Lowered to $36 at Goldman Sachs

Member Login

Free News Feed